Quickly read this. Brilliant news & also for CDx indication. I’m not quoting, but DXB ASX are using PromarkerD in clinical trials at present for FSGS & DKD (umbrella CKD). The collaboration between PIQ & DXB has been long standing. There may be some data sharing there too, whatever is the best outcome for patients & ethics. Janssen is our biggest hope. GLTAH
Ann: US patent for identifying drugs for abnormal kidney function, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.015(4.92%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 28.5¢ | $191.2K | 643.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53694 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 51000 | 2 |
View Market Depth
| Last trade - 15.36pm 26/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |